JNJ

170.73

-0.23%↓

ABBV

198.59

+0.8%↑

AZN

74.43

-0.13%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

JNJ

170.73

-0.23%↓

ABBV

198.59

+0.8%↑

AZN

74.43

-0.13%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

JNJ

170.73

-0.23%↓

ABBV

198.59

+0.8%↑

AZN

74.43

-0.13%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

JNJ

170.73

-0.23%↓

ABBV

198.59

+0.8%↑

AZN

74.43

-0.13%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

JNJ

170.73

-0.23%↓

ABBV

198.59

+0.8%↑

AZN

74.43

-0.13%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

Search

Harmony Biosciences Holdings Inc

Geschlossen

BrancheGesundheitswesen

35.13 -0.93

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

32.59

Max

35.32

Schlüsselkennzahlen

By Trading Economics

Einkommen

-3.9M

46M

Verkäufe

-17M

185M

KGV

Branchendurchschnitt

13.114

34.393

Gewinnspanne

24.663

Angestellte

268

EBITDA

-10M

56M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+38.94% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

28. Okt. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

301M

2B

Vorheriger Eröffnungskurs

36.06

Vorheriger Schlusskurs

35.13

Nachrichtenstimmung

By Acuity

34%

66%

108 / 374 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Weak Bullish Evidence

Harmony Biosciences Holdings Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

5. Aug. 2025, 23:11 UTC

Ergebnisse

Australia's REA Hikes Dividend as Annual Profit Rises 23% -- Update

5. Aug. 2025, 22:45 UTC

Ergebnisse

Australia's REA Hikes Dividend as Annual Profit Rises 23%

5. Aug. 2025, 22:39 UTC

Ergebnisse

Great-West Lifeco Logs Lower 2Q Profit

5. Aug. 2025, 21:32 UTC

Ergebnisse

Coupang Posts Higher 2Q Sales Due to Customer Growth

6. Aug. 2025, 00:00 UTC

Akquisitionen, Fusionen, Übernahmen

NFL to Take 10% Stake in Disney's ESPN -- WSJ

6. Aug. 2025, 00:00 UTC

Akquisitionen, Fusionen, Übernahmen

The NFL Is Taking a 10% Stake in Disney's ESPN -- WSJ

6. Aug. 2025, 00:00 UTC

Akquisitionen, Fusionen, Übernahmen

Disney to Take Control of NFL Network as Part of Agreement -- WSJ

6. Aug. 2025, 00:00 UTC

Akquisitionen, Fusionen, Übernahmen

Disney, NFL Strike Wide-Reaching Media-Asset Deal -- WSJ

5. Aug. 2025, 23:48 UTC

Market Talk

Nikkei May Decline Amid U.S. Economic Uncertainty -- Market Talk

5. Aug. 2025, 23:40 UTC

Market Talk

Gold Edges Higher, Supported by Fed Rate-Cut Hopes -- Market Talk

5. Aug. 2025, 23:19 UTC

Market Talk

Lindian Deal With Iluka Demonstrates Kangankunde Project Appeal -- Market Talk

5. Aug. 2025, 23:03 UTC

Market Talk
Ergebnisse

Advanced Micro Devices' Data-Center Story Seen as Promising -- Market Talk

5. Aug. 2025, 22:22 UTC

Ergebnisse

REA: Expectation of More Interest-Rate Cuts Likely to Support Buyer Demand>REA.AU

5. Aug. 2025, 22:21 UTC

Ergebnisse

REA Expects FY26 Listing Volumes Broadly Flat on FY25>REA.AU

5. Aug. 2025, 22:20 UTC

Ergebnisse

REA Expects September-Quarter Listings to Be Down on Year>REA.AU

5. Aug. 2025, 22:18 UTC

Ergebnisse

REA July 2025 New Residential Listings Down 8% on Year>REA.AU

5. Aug. 2025, 22:17 UTC

Ergebnisse

REA FY25 Australian Residential Listings Up 1% on Year>REA.AU

5. Aug. 2025, 22:17 UTC

Ergebnisse

REA FY25 India Revenue A$129M Vs. A$103M>REA.AU

5. Aug. 2025, 22:16 UTC

Ergebnisse

REA FY25 Core Australia Revenue A$1.54B Vs. A$1.35B>REA.AU

5. Aug. 2025, 22:16 UTC

Ergebnisse

REA FY25 Core Operations Net Profit A$564.4M Vs. A$460.5M>REA.AU

5. Aug. 2025, 22:15 UTC

Ergebnisse

REA Group FY25 Ebitda A$969.2M Vs. A$824.8M>REA.AU

5. Aug. 2025, 22:13 UTC

Ergebnisse

REA Group Raises Dividend to A$1.38 Vs. A$1.02 >REA.AU

5. Aug. 2025, 22:13 UTC

Ergebnisse

REA Group FY25 Rev A$1.67B Vs. A$1.45B >REA.AU

5. Aug. 2025, 22:12 UTC

Ergebnisse

REA FY25 Core Operations Net Profit A$564.4M Vs, A$460.5M>REA.AU

5. Aug. 2025, 22:12 UTC

Ergebnisse

REA Group FY25 Net A$677.9M Vs. Net A$302.8M >REA.AU

5. Aug. 2025, 21:58 UTC

Ergebnisse

Novo Nordisk's Earnings Come After a Dramatic Guidance Cut. What to Look for Now. -- Barrons.com

5. Aug. 2025, 21:30 UTC

Ergebnisse

AMD Gives a Strong Outlook. Why the Stock Is Falling. -- Barrons.com

5. Aug. 2025, 21:26 UTC

Ergebnisse

AMD CEO Expects Embedded Segment to Return to Sequential Growth in Back Half of 2025

5. Aug. 2025, 21:23 UTC

Ergebnisse

AMD CEO Sees Strong Customer Interest in MI400 Series for Large-Scale Deployments

5. Aug. 2025, 21:17 UTC

Ergebnisse

AMD Expects Steep Production Ramp for MI350 Series in Back Half of Year, CEO Says

Peer-Vergleich

Kursveränderung

Harmony Biosciences Holdings Inc Prognose

Kursziel

By TipRanks

38.94% Vorteil

12-Monats-Prognose

Durchschnitt 49.38 USD  38.94%

Hoch 70 USD

Tief 31 USD

Basierend auf 8 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Harmony Biosciences Holdings Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

8 ratings

6

Buy

1

Halten

1

Sell

Technischer Score

By Trading Central

29.8 / N/AUnterstützung & Widerstand

Kurzfristig

Weak Bullish Evidence

Mittelfristig

Weak Bullish Evidence

Langfristig

Very Strong Bearish Evidence

Stimmung

By Acuity

108 / 374 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.